Searched for
ADCOCK INGRAM
Natco Pharma to acquire significant stake in S African firm Adcock IngramIndian pharmaceutical company Natco Pharma is set to acquire significant stakes in South Africa's Adcock Ingram, a 135-year-old firm, in a ...- Natco Pharma shares dip over 2% after Rs 2,000-crore stake buy in South Africa’s Adcock IngramNatco’s proposed all-cash deal to acquire nearly 36% of AIHL from minority shareholders is aimed at expanding its presence in South Africa,...
- Natco Pharma to buy over 35% in South Africa's Adcock IngramNatco Pharma, based in Hyderabad, is set to acquire a 35.75% stake in Adcock Ingram, South Africa's second-largest drugmaker, for ₹2,000 cr...
- Natco Pharma offers to acquire nearly 36% stake in Adcock Ingram in Rs 2,100-cr dealNatco Pharma has made a firm offer to acquire nearly 36% stake in South African drug firm Adcock Ingram Holdings for up to Rs 2,100 crore. ...
- Karnataka govt approves 48 industrial projects worth Rs 2,062 crA panel has considered and approved seven important large and medium size industrial projects worth Rs 1,275.67 crore, which are expected t...
- Sun Pharmaceutical, Dr Reddy's Labs, JB Pharmaceuticals, Torrent Pharma and Piramal Pharma eye Oaknet HealthcareAnother mid-sized pharma firm, La Renon, backed by Sequoia Capital and A91 Partners is also keen on buying out Oaknet. Binding bids will be...
- Hyderabad-based Natco Pharma wants to make Eli Lilly’s Covid drugNatco has sought nod for the manufacture and marketing of baricitinib bulk drug and tablets in 1 to 4 mg versions in India. This move may t...
- Reliance plans to buy e-pharmacy NetmedsThe conversations between Reliance and Netmeds, which had also held talks with Walmart-owned Flipkart, had been going on before the coronav...
- Samara Capital likely to buy Novartis brands"Samara Capital is bullish on this segment and 7-8 brands which are part of the anti-infective portfolio will be acquired as part of the de...
- Adcock Ingram in pact for strategic sale of Indian operationSouth Africa's second biggest drug marker Adcock Ingram has confirmed it has found a buyer for the Indian marketing and sales operations.
- South Africa's Adcock in talks to sell part of its India businessSouth Africa’s second largest drug maker Adcock Ingram is in advanced talks to sell part of its India business to Oaknet Lifesciences.
- Carlyle, Kedaara, others in talks to buy Cosme FarmaAdcock, which had acquired unlisted Cosme in 2012 for Rs 480 crore, has initiated the process of selling it, they said.
- Unichem plans sale of domestic formulations business; valuation seen at $1-1.2 billionInvestment bank Jefferies has been hired to seek potential suitors. The valuation could be $1-1.2 billion, said one of those cited above.
- Japan’s Meiji Holdings acquires Medreich for Rs 1,720 crore“The Meiji Group wants to enter the global generics field, particularly in Asia and emerging countries,” said the company press release.
- Ranbaxy drugs are 'safe and efficacious': South African regulatorGeneric drugs distributed in South Africa by Indian pharmaceutical giant Ranbaxy are "safe" and "efficacious", the country's regulator body...
- FDC owners in talks to exit; plan to sell their 67% stakeBuyout fund Carlyle had shown interest in buying the company and had even valued it at about Rs 3,800 crore.
- Govt clears 12 FDI proposals worth Rs 707 croreThe government has cleared 12 FDI proposals, including the ones by UK's footwear chain Pavers England and America's oldest clothing retaile...
- South Africa-based Adcock Ingram buys Cosme Farma for Rs 480 croreSouth Africa-based drug maker Adcock Ingram has quietly acquired privately-held Cosme Farma for Rs 480 crore, a 13 times premium over Cosme...
- Indian firm sues South Africa after losing AIDS drug contractAn Indian manufacturer of drugs to treat HIV/AIDS is suing the South African government after failing to clinch a $400-million tender, Sout...
- Adcock's plan to buy Medpro hits Cipla hurdleSouth African company Adcock Ingram's plans to buy Cipla Medpro, with whom Cipla has a 20-year drug-supply agreement, has run into trouble ...
Load More
